Outreach

ASGCT Expands Biotech Teacher Training Program with Milwaukee Public Schools

Alex Wendland - March 17, 2023

ASGCT will continue an innovative program to provide Milwaukee teachers with curriculum training and lab equipment so they can bring biotechnology experiments into their classrooms.

The American Society of Gene and Cell Therapy (ASGCT) will continue an innovative program to provide Milwaukee teachers with curriculum training and lab equipment so they can bring biotechnology experiments into their classrooms.

A generous two-year grant from Bristol Myers Squibb will support expenses related to the continuation and expansion of the program Biotech Discovery Labs: Teacher Training and Classroom Experience, which was piloted in 2022. The program aims to increase access to the booming biotechnology field through health and science education within Milwaukee Public Schools (MPS).

ASGCT invites 15 teachers from MPS middle and high schools to participate in in-person lab training at the Society’s Milwaukee-area office July 17-20. With the help of ASGCT staff, they’ll use supplies covered by the grant to perform and teach experiments on DNA extraction, fingerprinting, and transformation; introduction to gel electrophoresis; CRISPR; and PCR. Teachers will also be invited to attend ASGCT’s Annual Meeting and the National Science Teaching Association Conference. In July 2024, the program will expand to 20 teachers.

The idea for this program came from ASGCT’s desire to expand its diversity, equity, and inclusion (DEI) efforts beyond initiatives that target only post-doctoral researchers. By exposing students to science earlier in their education, ASGCT hopes to spark their interest sooner and improve access to better opportunities after graduation. ASGCT piloted the project last summer with teachers from four MPS schools. Some of those teachers will serve as program volunteers during this summer’s training.

More information will be available on ASGCT’s website in the coming months. Please direct any questions about this program to Alex Wendland, ASGCT director of communications.

Related Articles

Outreach

The Impact of Genetic Testing on Rare Disease Treatments

Alexis Starosta - October 07, 2024
Outreach

Exploring Barriers to Accessing Gene and Cell Therapy Treatments

Alexis Starosta - August 26, 2024

Maria Santaella, PhD (c), MSN, RN-BC, CPHON serves as the Vice President of Research for the National Bleeding Disorders Foundation. During the workshop she spoke on clinical trial enrollment by sharing strategies to address barriers in recruiting.

Annual Meeting 2024

Inclusive Trial Design Amplifies Patient Voices and Drives Meaningful Outcomes

Samuel Hughes, MBA, St. Jude Children's Research Hospital - June 18, 2024
Outreach

Community Quick Takes Provide Expert Perspectives on Timely Topics

Alexis Starosta - February 28, 2024